CARMEL, Ind., Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today its participation in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, taking place December 3-4 in Boca Raton, Florida.

Syra Health CEO, Dr. Deepika Vuppalanchi, will present at the prestigious event, which highlights emerging growth companies. Dr. Vuppalanchi will deliver the Company's presentation on December 3 at 2:00 p.m. ET. The presentation will highlight Syra Health's healthcare solutions, designed to address the growing mental health crisis, other chronic conditions, and child welfare challenges, while delivering both improved patient outcomes and public health advancements. These innovative approaches are particularly impactful in regions where the demand for accessible, affordable, and high-quality care is rapidly increasing, reflecting Syra's commitment to fostering healthier communities and driving meaningful change.

"We are excited to present Syra Health's innovations at the Noble Conference," said Dr. Vuppalanchi. "This platform provides an excellent opportunity to engage with investors to discuss how our solutions are transforming healthcare, improving outcomes, and driving access and affordability across the system."

Following the presentation, Dr. Vuppalanchi will engage in a fireside chat, offering further insights into Syra Health's strategy and vision for the future. In addition to the presentation and fireside chat, Dr. Vuppalanchi will participate in one-on-one meetings with investors. Syra Health's CFO, Priya Prasad, will also attend the event.

Syra Health's financial outlook is robust, with strong revenue growth and an expanding market presence. The Company is well-positioned to capitalize on the increasing demand for its innovative healthcare solutions and to continue driving value for stakeholders.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.

Forward-Looking Statements 

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For Investor or Media Inquiries:
Christine Drury
IR/PR
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.